Änderungen

66 Bytes hinzugefügt ,  20:16, 31. Mär. 2020
Zeile 24: Zeile 24:     
''"Quadrivalent HPV (HPV4) vaccine (Gardasil, Merck) was approved by the FDA in June 2006. The vaccine is approved for females and males 9 through 26 years of age. Each 0.5-mL dose of HPV4 contains 20 micrograms HPV 6 L1 protein, 40 micrograms HPV 11 L1 protein, 40 micrograms HPV 16 L1 protein, and 20 micrograms HPV 18 L1 protein."''<ref> [https://www.cdc.gov/vaccines/pubs/pinkbook/hpv.html#hpv CDC Pinkbook HPV]</ref>
 
''"Quadrivalent HPV (HPV4) vaccine (Gardasil, Merck) was approved by the FDA in June 2006. The vaccine is approved for females and males 9 through 26 years of age. Each 0.5-mL dose of HPV4 contains 20 micrograms HPV 6 L1 protein, 40 micrograms HPV 11 L1 protein, 40 micrograms HPV 16 L1 protein, and 20 micrograms HPV 18 L1 protein."''<ref> [https://www.cdc.gov/vaccines/pubs/pinkbook/hpv.html#hpv CDC Pinkbook HPV]</ref>
 +
===Behauptungen zu sterilisierendem Tetanus-Impfstoff in Kenia===
    
==Finanzierung==
 
==Finanzierung==
594

Bearbeitungen